miR-204 indirectly inhibits TRPM3-mediated downstream LC3B-related autophagy through Cav-1, thereby inhibiting the progression of clear cell renal cell carcinoma. This evidence concerns the gene MAP1LC3B and clear cell renal carcinoma.